What’s new in rectal cancer ?

##plugins.themes.academic_pro.article.sidebar##

Published Feb 17, 2015
Download
pdf
Vol. 92 No. 10 (2014): Issue Oct 2014

##plugins.themes.academic_pro.article.main##

Sadreddine Ben Abid
Rania Hefaiedh
Zeineb Mzoughi
Nizar Miloudi
Arfaa Naafa
Med Tahar Khalfallah

Abstract

Background: In recent years, multidisciplinary therapeutic management of rectal cancer has evolved. This progress had interest radio and chemotherapy. Aim: To describe the main spots of the progress in the therapeutic strategies of the disease, surgical techniques and standardization of these techniques, particularly regarding locoregional extension in the mesorectum.

Method: Literature review.

Results: Treatment of rectal cancer is multidisciplinary. On the surgical field, excision of the mesorectum (total mesorectal excision [TME]) has reduced local recurrence and the genitourinary sequelae. Meanwhile, chemoradiotherapy has become important. The standard now is to indicate to T3 T4 N+ tumors to decrease local recurrence without improving survival, however.

Conclusion: Advances in the management of rectal cancer with both imaging progress and therapeutic modalities have improved the prognosis and survival of this cancer.

Keywords:

Rectal cancer - Mesorectum - Radiotherapy - Chimiotherapy - Surgery - Recurrence

##plugins.themes.academic_pro.article.details##

References

  1. Cherif R. Monographie de l'Association Tunisienne de chirurgie. Les adénocarcinomes du rectum. 28ème congrès national de chirurgie. Mars 2007.
  2. Heald RJ, Husband EM, Ryall RDH. The mesorectum in rectal cancer surgery: the clue to pelvic recurrence. Br J Surg 1982 ; 69 : 613-6.
  3. Beets-Tan RG, Beets GL, Vliegen RF et al. Accuracy of magnetic resonance imaging in prediction of tumor-free resection margin in rectal cancer surgery. Lancet 2001; 357: 497-504.
  4. Brown G, Richards CJ, Newcombe RG et al. Rectal carcinoma: thin-section MR imaging for staging in 28 patients. Radiology 1999; 211: 215-22.
  5. Brown G, Radcliffe AG, Newcombe RG, et al. Preoperative assessment of prognostic factors in rectal cancer using high-resolution magnetic resonance imaging. Br J Surg 2003; 90: 355-64.
  6. Lahaye MJ, Engelen SM, Nelemans PJ, et al. Imaging for predicting the risk factors- - the circumferential resection margin and nodal disease--of local recurrence in rectal cancer: a meta-analysis. Semin Ultrasound CT MR 2005; 26: 259-68.
  7. Blomqvist L, Machado M, Rubio C, et al. Rectal tumor staging: MR imaging using pelvic phased-array and endorectal coils Vs endoscopic ultrasonography. Eur Radiol 2000; 10: 653-60
  8. Gagliardi G, Bayar S, Smith R, Salem RR. Preoperative staging of rectal cancer using magnetic resonance imaging with external phase-arrayed coils. Arch Surg 2002; 137: 447-51
  9. Brown G, Richard CJ, Bourne MW, et al. Morphologic predictors of lymph node status in rectal cancer with use of high-spatial-resolution MR imaging with histopathologic comparison. Radiology 2003; 227: 371-7.
  10. Koh DM, Brown G, Temple L, et al. Rectal cancer: mesorectal lymph nodes at MR imaging with USPIO versus histopathologic findings--initial observations. Radiology 2004; 231: 91-9.
  11. Smith NJ, Barbachano Y, Norman AR, et al. Prognostic significance of magnetic resonance imaging-detected extramural vascular invasion in rectal cancer. Br J Surg 2008; 95: 229-36.
  12. Curvo-Semedo L, Lambregts DM, Mass M, et al. Rectal cancer: assessment of complete response to preoperative combined radiation therapy with chemotherapyconventional MR volumetry versus diffusion-weighted MR imaging. Radiology 2011; 260: 734-43
  13. Bipat S, Glas AS, Slors FJ, et al. Rectal cancer: local staging and assessment of lymph node involvement with endoluminal US, CT and MR imaging in a metaanalysis. Radiology 2004; 232: 773-83.
  14. Kapiteijn E, Marijnen CA, Nagtegaal ID, et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 2001; 345: 638-46.
  15. Peeters KC, Marijnen CA, Nagtegaal ID, et al. The TME trial after a median followup of 6 years: increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma. Ann Surg 2007; 246: 693-701.
  16. Van Gijn W, Marijnen CA, Nagtegaal ID, et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre randomised controlled TME trial. Lancet Oncol 2011; 12: 575-82
  17. Gérard JP, Conroy T, Bonnetain F, et al. Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203. J Clin Oncol 2006; 24: 4620-5.
  18. Fiorica F, Cartei F, Licata A, et al. Can chemotherapy concomitantly delivered with radiotherapy improve survival of patients with resectable rectal cancer? A metaanalysis of literature data. Cancer Treat Rev 2010; 36: 539-49.
  19. Van Custem E, Dicato M, Haustermans K, et al. The diagnosis and management of rectal cancer: expert discussion and recommendations derived from the 9 th world congress on gastrointestinal cancer, Barcelona, 2007. Ann Oncol 2008; 19 suppl 6:vi1-8.
  20. Bosset JF, Collette L, Calais G, et al. Chemotherapy with preoperative radiotherapy in rectal cancer. N Eng J Med 2006; 355: 1114-23
  21. Fountzilas G, Zisiadis A, Dafni U, et al. Postoperative radiation and concomitant bolus fluorouracil with or without additional chemotherapy with fluorouracil and highdose leucovorin in patients with high-risk rectal cancer: a randomized phase III study conducted by the Hellenic Cooperative Oncology Group.Ann Oncol 1999; 10: 671-6.
  22. Sakamoto J, Ohashi Y, Hamada C, et al. Meta-analysis group of the Japanese society for cancer of the colon and rectum : Meta-analysis Group in cancer. Efficacy of oral adjuvant therapy after resection of colorectal cancer: 5-year results from three randomized trials. J Clin Oncol 2004; 22: 484-92.
  23. Sakamoto J, Hamada C, Yoshida S, et al. An individual patient data meta-analysis of adjuvant therapy with uracil-tegafur (UFT) in patients with curatively resected rectal cancer. Br J Cancer 2007; 96: 1170-7.
  24. Arban G, Nilsson E, Hallbook sjodahl R. Local recurrence following total mesorectal excision for rectal cancer. Br J Surg 1996; 83: 375-9.
  25. Wibe A, Moller B, Norstein J, et al. A national strategic change in treatment policy for rectal cancer. Implementation of total mesorectal excision as routine treatment in Norway. A national audit. Dis Colon Rectum 2002; 45: 857-66.
  26. Nagtegaal ID, van de Velde CJ, van der Worp E, et al. Macroscopic evaluation of rectal cancer resection specimen. Clinical significance of the pathologist in quality control. J Clin Oncol 2002; 20:1729-34.
  27. Maurer CA, Z'Graggen, Renzulli P, et al. Total mesorectal excision preserves male genital function compared with conventional rectal cancer surgery. Br J Surg 2001; 88; 1501-5.
  28. Rouanet P, Saint-Aubert B, Lemanski C, et al. Restorative and non restorative surgery for low rectal cancer after high-dose radiation: long term oncologic and functional results. Dis Colon Rectum 2002; 405: 305-13.
  29. Valentini V, Coco C, Picciocchi A, et al. Does down staging predict improved outcome after preoperative chemoradiation for extra-peritoneal locally advanced rectal cancer? A long-term analysis of 165 patients. Int J Radiat Oncol Biol Phys 2002; 53: 664-74
  30. Weiser MR, Quah HM, Shia J, et al. Sphincter preservation in low rectal cancer is facilitated by preoperative chemoradiation and inter-sphincteric dissection. Ann Surg 2009; 249: 236-42.
  31. Wong RK, Tandan V, De Silva S, Figueredo A. Pre-operative radiotherapy and curative surgery for the management of localized rectal carcinoma. Cochrane Database Syst Rev 2007; 2: CD002102.
  32. Bujko K, Kepka L, Michalski W, Nowacki MP. Does rectal cancer shrinkage induced by preoperative radio(chemo)therapy increase the likelihood of anterior resection? A systematic review of randomised trials. Radiother Oncol 2006; 80: 4-12.
  33. Sauer R, Becker H, Hohenberger W, et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 2004; 351: 1731-40.
  34. Mauvais F, Sabbagh C, Brehant O, et al. Amputation abdomino-périnéale dans la prise en charge des cancers du bas rectum (1): problématique carcinologique et technique d'exérèse. J Chir Visc 2011: 148, 98-107.
  35. Eriksen MT, Wibe A, Syse A, et al. Inadvertent perforation during rectal cancer resection in Norway. Br J Surg 2004; 91: 210-6.
  36. Nagtegaal ID, van de Velde CJ, Marijnen CA, et al. Pathology review committee. Low rectal cancer: a call for a change of approach in abdomino-perineal resection. J Clin Oncol 2005; 23: 9257-64.
  37. Nisar PJ, Scott HJ. Myocutaneous flap reconstruction of the pelvis after abdominoperineal excision. Colorectal Dis 2009; 11: 806-16.
  38. Guillou PJ, Quirke P, Thorpe H, et al. Short-term endpoints of conventional versus laparoscopic-assisted surgery in patients with colorectal cancer (MRC CLASICC trial): multicentre randomized controlled trial. Lancet 2005; 365: 1718-26
  39. Laurent C, Leblanc F, Gineste C, et al. Laparoscopic approach in surgical treatment of rectal cancer. Br J Surg 2007; 94: 1555-61.
  40. Anderson C, Uman G, Pigazzi A. Oncologic outcomes of laparoscopic surgery for rectal cancer: a systematic review and meta-analysis of the literature. Eur J Surg Oncol 2008; 34:1135-42.
  41. aurent C, Leblanc F, Wütrich P, et al. Laparoscopic versus open surgery for rectal cancer: long-term oncologic results. Ann Surg 2009; 250: 54-61.
  42. Quah HM, Jayne DG, Eu KW, Seow-Choen F. Bladder and sexual dysfunction following laparoscopically assisted and conventional open mesorectal resection for cancer. Br J Surg 2002; 89: 1551-6.
  43. Bretagnol F, Merrie A, George B, et al. Local excision of rectal tumors by transanal endoscopic microsurgery. Br J Surg 2007; 94: 627-633.
  44. Nagtegaal ID, van Krieken JH. The role of pathologists in the quality control of diagnosis and treatment of rectal cancer-an overview. Eur J Cancer 2002; 38: 964-72
  45. Berrino F, De Angelis R, Sant M, et al. Survival for eight major cancers and all cancers combined for European adults diagnosed in 1995-99: results of the EUROCARE-4 study. Lancet Oncol 2007; 8: 773-83.
  46. Manfredi S, Benhamiche AM, Meny B, et al. Population based study of factors influencing occurrence and prognosis of local recurrence after surgery for rectal cancer. Br J Surg 2001; 88: 1221-7.